{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:13:24Z","timestamp":1789586004642,"version":"build-2803163510"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Product Development Pilot Award from the Joint Department of Biomedical Engineering at Marquette University and the Medical College of Wisconsin","award":["Product Development Pilot Award from the Joint Department of Biomedical Engineering at Marquette University and the Medical College of Wisconsin"],"award-info":[{"award-number":["Product Development Pilot Award from the Joint Department of Biomedical Engineering at Marquette University and the Medical College of Wisconsin"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s13346-025-01968-9","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T18:34:23Z","timestamp":1757961263000},"page":"1547-1560","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Image-guided in vivo evaluation and comparison of bone-targeting peptides for therapeutic intervention"],"prefix":"10.1007","volume":"16","author":[{"given":"Austin","family":"Stellpflug","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linxia","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongxue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3326-6887","authenticated-orcid":false,"given":"Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"key":"1968_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1146\/annurev.bioeng.1.1.19","volume":"1","author":"CT Laurencin","year":"1999","unstructured":"Laurencin CT, et al. Tissue engineering: orthopedic applications. Annu Rev Biomed Eng. 1999;1:19\u201346.","journal-title":"Annu Rev Biomed Eng"},{"issue":"1","key":"1968_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1586\/17434440.3.1.49","volume":"3","author":"C Laurencin","year":"2006","unstructured":"Laurencin C, Khan Y, El-Amin SF. Bone graft substitutes. Expert Rev Med Devices. 2006;3(1):49\u201357.","journal-title":"Expert Rev Med Devices"},{"issue":"2","key":"1968_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1615\/JLongTermEffMedImplants.v21.i2.10","volume":"21","author":"AR Amini","year":"2011","unstructured":"Amini AR, Wallace JS, Nukavarapu SP. Short-term and long-term effects of orthopedic biodegradable implants. J long Term Eff Med Implants. 2011;21(2):93\u2013122.","journal-title":"J long Term Eff Med Implants"},{"issue":"3","key":"1968_CR4","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/jbmr.2072","volume":"29","author":"S Amin","year":"2014","unstructured":"Amin S, et al. Trends in fracture incidence: a population-based study over 20 years. J Bone Min Res. 2014;29(3):581\u20139.","journal-title":"J Bone Min Res"},{"issue":"7","key":"1968_CR5","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1002\/art.39692","volume":"68","author":"JM Hootman","year":"2016","unstructured":"Hootman JM, et al. Updated projected prevalence of Self-Reported Doctor-Diagnosed arthritis and arthritis-Attributable activity limitation among US adults, 2015\u20132040. Arthritis Rheumatol. 2016;68(7):1582\u20137.","journal-title":"Arthritis Rheumatol"},{"key":"1968_CR6","doi-asserted-by":"publisher","first-page":"174550572311766","DOI":"10.1177\/17455057231176655","volume":"19","author":"U Amin","year":"2023","unstructured":"Amin U, et al. An overview of the management of osteoporosis in the aging female population. Womens Health (Lond). 2023;19:17455057231176655.","journal-title":"Womens Health (Lond)"},{"key":"1968_CR7","doi-asserted-by":"publisher","first-page":"116895","DOI":"10.1016\/j.bone.2023.116895","volume":"176","author":"L Michou","year":"2023","unstructured":"Michou L, et al. Prevalence and incidence of paget\u2019s disease of bone: Temporal trend over 20 years in the Province of quebec, Canada. Bone. 2023;176:116895.","journal-title":"Bone"},{"issue":"1","key":"1968_CR8","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13023-023-02849-5","volume":"18","author":"H Yu","year":"2023","unstructured":"Yu H, et al. Pathogenic mechanisms of osteogenesis imperfecta, evidence for classification. Orphanet J Rare Dis. 2023;18(1):234.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"1968_CR9","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.bjae.2023.01.005","volume":"23","author":"E Chan","year":"2023","unstructured":"Chan E, DeVile C, Ratnamma VS. Osteogenesis imperfecta. BJA Educ. 2023;23(5):182\u20138.","journal-title":"BJA Educ"},{"issue":"6","key":"1968_CR10","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1111\/bcp.13791","volume":"85","author":"T Kehoe","year":"2019","unstructured":"Kehoe T, Blind E, Janssen H. Regulatory aspects of the development of drugs for metabolic bone diseases - FDA and EMA perspective. Br J Clin Pharmacol. 2019;85(6):1208\u201312.","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"1968_CR11","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1080\/13543784.2023.2263352","volume":"32","author":"F Migliorini","year":"2023","unstructured":"Migliorini F, et al. Pharmacological agents for bone fracture healing: talking points from recent clinical trials. Expert Opin Investig Drugs. 2023;32(9):855\u201365.","journal-title":"Expert Opin Investig Drugs"},{"key":"1968_CR12","doi-asserted-by":"publisher","first-page":"837430","DOI":"10.3389\/fcell.2022.837430","volume":"10","author":"Z Liu","year":"2022","unstructured":"Liu Z, et al. Overview of physical and Pharmacological therapy in enhancing bone regeneration formation during distraction osteogenesis. Front Cell Dev Biol. 2022;10:837430.","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"1968_CR13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.11005\/jbm.2020.27.3.175","volume":"27","author":"VMD Rocha","year":"2020","unstructured":"Rocha VMD, et al. Use of bisphosphonates, calcium and vitamin D for bone demineralization in patients with human immunodeficiency virus\/acquired immune deficiency syndrome: A systematic review and Meta-Analysis of clinical trials. J Bone Metab. 2020;27(3):175\u201386.","journal-title":"J Bone Metab"},{"issue":"5","key":"1968_CR14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/13543776.2019.1608180","volume":"29","author":"SA Holstein","year":"2019","unstructured":"Holstein SA. A patent review of bisphosphonates in treating bone disease. Expert Opin Ther Pat. 2019;29(5):315\u201325.","journal-title":"Expert Opin Ther Pat"},{"issue":"5","key":"1968_CR15","first-page":"766","volume":"25","author":"JD Ringe","year":"2007","unstructured":"Ringe JD, Body JJ. A review of bone pain relief with ibandronate and other bisphosphonates in disorders of increased bone turnover. Clin Exp Rheumatol. 2007;25(5):766\u201374.","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"1968_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.7326\/ACPJC-2006-145-3-071","volume":"145","author":"DC Bauer","year":"2006","unstructured":"Bauer DC. Review: human parathyroid hormone reduces fractures and increases bone mineral density in severe osteoporosis. ACP J Club. 2006;145(3):71.","journal-title":"ACP J Club"},{"issue":"6","key":"1968_CR17","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00223-010-9420-x","volume":"87","author":"SJ Gallacher","year":"2010","unstructured":"Gallacher SJ, Dixon T. Impact of treatments for postmenopausal osteoporosis (bisphosphonates, parathyroid hormone, strontium ranelate, and denosumab) on bone quality: a systematic review. Calcif Tissue Int. 2010;87(6):469\u201384.","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"1968_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/jbm4.10005","volume":"1","author":"KM Kim","year":"2017","unstructured":"Kim KM, Lee SY, Rhee Y. Influence of dosing interval and administration on the bone metabolism, skeletal effects, and clinical efficacy of parathyroid hormone in treating osteoporosis: A narrative review. JBMR Plus. 2017;1(1):36\u201345.","journal-title":"JBMR Plus"},{"issue":"4","key":"1968_CR19","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1080\/02841860802001467","volume":"47","author":"NH Bjarnason","year":"2008","unstructured":"Bjarnason NH, et al. Adverse bone effects during Pharmacological breast cancer therapy. Acta Oncol. 2008;47(4):747\u201354.","journal-title":"Acta Oncol"},{"key":"1968_CR20","doi-asserted-by":"crossref","unstructured":"Boehm E et al. Real-life effects of Pharmacological osteoporosis treatments on bone mineral density by quantitative computed tomography. J Bone Min Metab, 2024.","DOI":"10.1007\/s00774-024-01553-z"},{"issue":"2","key":"1968_CR21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/8756-3282(95)00445-9","volume":"18","author":"JH Lin","year":"1996","unstructured":"Lin JH. Bisphosphonates: a review of their Pharmacokinetic properties. Bone. 1996;18(2):75\u201385.","journal-title":"Bone"},{"issue":"12","key":"1968_CR22","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.addr.2012.05.017","volume":"64","author":"K Aoki","year":"2012","unstructured":"Aoki K, et al. Peptide-based delivery to bone. Adv Drug Deliv Rev. 2012;64(12):1220\u201338.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"1968_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.nano.2016.08.015","volume":"13","author":"EJ Carbone","year":"2017","unstructured":"Carbone EJ, et al. Osteotropic nanoscale drug delivery systems based on small molecule bone-targeting moieties. Nanomedicine. 2017;13(1):37\u201347.","journal-title":"Nanomedicine"},{"key":"1968_CR24","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.2147\/IJN.S44393","volume":"8","author":"W Gu","year":"2013","unstructured":"Gu W, et al. Nanotechnology in the targeted drug delivery for bone diseases and bone regeneration. Int J Nanomed. 2013;8:2305\u201317.","journal-title":"Int J Nanomed"},{"issue":"7","key":"1968_CR25","doi-asserted-by":"publisher","first-page":"789","DOI":"10.2174\/156800909789760429","volume":"9","author":"M Caraglia","year":"2009","unstructured":"Caraglia M, Santini D. Target therapy of bone metastases and tumours. Curr Cancer Drug Targets. 2009;9(7):789\u201390.","journal-title":"Curr Cancer Drug Targets"},{"issue":"20","key":"1968_CR26","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.2174\/092986712801215865","volume":"19","author":"K Ogawa","year":"2012","unstructured":"Ogawa K, Washiyama K. Bone target radiotracers for palliative therapy of bone metastases. Curr Med Chem. 2012;19(20):3290\u2013300.","journal-title":"Curr Med Chem"},{"issue":"1","key":"1968_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1517\/14712598.2013.843667","volume":"14","author":"C Rolfo","year":"2014","unstructured":"Rolfo C, et al. Molecular target therapy for bone metastasis: starting a new era with denosumab, a RANKL inhibitor. Expert Opin Biol Ther. 2014;14(1):15\u201326.","journal-title":"Expert Opin Biol Ther"},{"key":"1968_CR28","doi-asserted-by":"crossref","unstructured":"Sonoda S, Yamaza T. A new target of dental Pulp-Derived stem Cell-Based therapy on recipient bone marrow niche in systemic lupus erythematosus. Int J Mol Sci, 2022. 23(7).","DOI":"10.3390\/ijms23073479"},{"issue":"10","key":"1968_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10856-020-06409-2","volume":"31","author":"F Heidari","year":"2020","unstructured":"Heidari F, et al. 3D construct of hydroxyapatite\/zinc oxide\/palladium nanocomposite scaffold for bone tissue engineering. J Mater Sci Mater Med. 2020;31(10):85.","journal-title":"J Mater Sci Mater Med"},{"key":"1968_CR30","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ijbiomac.2015.05.009","volume":"80","author":"M Shakir","year":"2015","unstructured":"Shakir M, et al. Nano-hydroxyapatite\/chitosan-starch nanocomposite as a novel bone construct: synthesis and in vitro studies. Int J Biol Macromol. 2015;80:282\u201392.","journal-title":"Int J Biol Macromol"},{"issue":"11","key":"1968_CR31","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1002\/jor.23222","volume":"34","author":"Y Shi","year":"2016","unstructured":"Shi Y, et al. Role of myeloid early endothelial progenitor cells in bone formation and osteoclast differentiation in tissue construct based on hydroxyapatite poly(ester-urethane) scaffolds. J Orthop Res. 2016;34(11):1922\u201332.","journal-title":"J Orthop Res"},{"issue":"4","key":"1968_CR32","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nmat1866","volume":"6","author":"D Taylor","year":"2007","unstructured":"Taylor D, Hazenberg JG, Lee TC. Living with cracks: damage and repair in human bone. Nat Mater. 2007;6(4):263\u20138.","journal-title":"Nat Mater"},{"issue":"1","key":"1968_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/1061186X.2014.950668","volume":"23","author":"T Singh","year":"2015","unstructured":"Singh T, et al. The critical role of bisphosphonates to target bone cancer metastasis: an overview. J Drug Target. 2015;23(1):1\u201315.","journal-title":"J Drug Target"},{"issue":"7","key":"1968_CR34","doi-asserted-by":"publisher","first-page":"854","DOI":"10.2174\/156800909789760393","volume":"9","author":"P Tassone","year":"2009","unstructured":"Tassone P, et al. Challenging the current approaches to multiple myeloma-related bone disease: from bisphosphonates to target therapy. Curr Cancer Drug Targets. 2009;9(7):854\u201370.","journal-title":"Curr Cancer Drug Targets"},{"issue":"12","key":"1968_CR35","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1007\/s40618-021-01634-0","volume":"44","author":"L Lorusso","year":"2021","unstructured":"Lorusso L, et al. Osteonecrosis of the jaw: a rare but possible side effect in thyroid cancer patients treated with tyrosine-kinase inhibitors and bisphosphonates. J Endocrinol Invest. 2021;44(12):2557\u201366.","journal-title":"J Endocrinol Invest"},{"key":"1968_CR36","doi-asserted-by":"publisher","first-page":"573976","DOI":"10.3389\/fendo.2020.573976","volume":"11","author":"ZR Domotor","year":"2020","unstructured":"Domotor ZR, et al. Oral treatment with bisphosphonates of osteoporosis does not increase the risk of severe Gastrointestinal side effects: A Meta-Analysis of randomized controlled trials. Front Endocrinol (Lausanne). 2020;11:573976.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"1968_CR37","doi-asserted-by":"publisher","first-page":"5696","DOI":"10.1002\/jcp.26465","volume":"233","author":"JW Vargas-Franco","year":"2018","unstructured":"Vargas-Franco JW, et al. Paradoxical side effects of bisphosphonates on the skeleton: what do we know and what can we do? J Cell Physiol. 2018;233(8):5696\u2013715.","journal-title":"J Cell Physiol"},{"issue":"18","key":"1968_CR38","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.4045\/tidsskr.12.0993","volume":"132","author":"S Loes","year":"2012","unstructured":"Loes S. Side effects of bisphosphonates. Tidsskr nor Laegeforen. 2012;132(18):2036. author reply 2036-7.","journal-title":"Tidsskr nor Laegeforen"},{"issue":"5","key":"1968_CR39","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1634\/theoncologist.2010-0225","volume":"16","author":"S Pozzi","year":"2011","unstructured":"Pozzi S, Raje N. The role of bisphosphonates in multiple myeloma: mechanisms, side effects, and the future. Oncologist. 2011;16(5):651\u201362.","journal-title":"Oncologist"},{"key":"1968_CR40","doi-asserted-by":"crossref","unstructured":"Kim JW et al. Genetically modified ferritin nanoparticles with bone-Targeting peptides for bone imaging. Int J Mol Sci, 2021. 22(9).","DOI":"10.3390\/ijms22094854"},{"issue":"4","key":"1968_CR41","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1021\/acs.biomac.3c01148","volume":"25","author":"M Halder","year":"2024","unstructured":"Halder M, et al. Investigating the role of amino acids in short peptides for hydroxyapatite binding and osteogenic differentiation of mesenchymal stem cells to aid bone regeneration. Biomacromolecules. 2024;25(4):2286\u2013301.","journal-title":"Biomacromolecules"},{"key":"1968_CR42","doi-asserted-by":"crossref","unstructured":"Zhang K et al. Functional calcium binding peptides from Pacific Cod (Gadus macrocephalus) bone: calcium bioavailability enhancing activity and Anti-Osteoporosis effects in the Ovariectomy-Induced osteoporosis rat model. Nutrients, 2018. 10(9).","DOI":"10.3390\/nu10091325"},{"issue":"7","key":"1968_CR43","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1021\/bm070121s","volume":"8","author":"MB Murphy","year":"2007","unstructured":"Murphy MB, et al. Synthesis and in vitro hydroxyapatite binding of peptides conjugated to calcium-binding moieties. Biomacromolecules. 2007;8(7):2237\u201343.","journal-title":"Biomacromolecules"},{"issue":"3","key":"1968_CR44","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s12307-011-0079-2","volume":"4","author":"P Wu","year":"2011","unstructured":"Wu P, Morgan GJ. Targeting bone as a therapy for myeloma. Cancer Microenviron. 2011;4(3):299\u2013311.","journal-title":"Cancer Microenviron"},{"key":"1968_CR45","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.bone.2018.06.003","volume":"114","author":"K Yang","year":"2018","unstructured":"Yang K, et al. A bone-targeting drug-delivery system based on semaphorin 3A gene therapy ameliorates bone loss in osteoporotic ovariectomized mice. Bone. 2018;114:40\u20139.","journal-title":"Bone"},{"issue":"8","key":"1968_CR46","doi-asserted-by":"publisher","first-page":"5413","DOI":"10.1007\/s10238-023-01235-6","volume":"23","author":"M Santoni","year":"2023","unstructured":"Santoni M, et al. Bone targeting agents, but not radiation therapy, improves survival in patients with bone metastases from advanced urothelial carcinoma receiving pembrolizumab: results from the ARON-2 study. Clin Exp Med. 2023;23(8):5413\u201322.","journal-title":"Clin Exp Med"},{"issue":"5","key":"1968_CR47","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s11914-020-00604-4","volume":"18","author":"JJ Nielsen","year":"2020","unstructured":"Nielsen JJ, Low SA. Bone-Targeting systems to systemically deliver therapeutics to bone fractures for accelerated healing. Curr Osteoporos Rep. 2020;18(5):449\u201359.","journal-title":"Curr Osteoporos Rep"},{"issue":"1","key":"1968_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00774-008-0004-z","volume":"27","author":"J Ishizaki","year":"2009","unstructured":"Ishizaki J, et al. Selective drug delivery to bone using acidic oligopeptides. J Bone Min Metab. 2009;27(1):1\u20138.","journal-title":"J Bone Min Metab"},{"issue":"2","key":"1968_CR49","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3109\/10611860108997922","volume":"9","author":"T Sekido","year":"2001","unstructured":"Sekido T, et al. Novel drug delivery system to bone using acidic oligopeptide: Pharmacokinetic characteristics and Pharmacological potential. J Drug Target. 2001;9(2):111\u201321.","journal-title":"J Drug Target"},{"key":"1968_CR50","doi-asserted-by":"crossref","unstructured":"Stellpflug A et al. From bone to nanoparticles: development of a novel generation of bone derived nanoparticles for image guided orthopedic regeneration. Biomater Sci, 2024.","DOI":"10.1039\/D4BM00391H"},{"issue":"4","key":"1968_CR51","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1080\/15476278.2020.1844507","volume":"16","author":"B Wang","year":"2020","unstructured":"Wang B, Li W, Harrison J. An evaluation of wound healing efficacy of a film dressing made from Polymer-integrated Amnion membrane. Organogenesis. 2020;16(4):126\u201336.","journal-title":"Organogenesis"},{"issue":"1","key":"1968_CR52","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jconrel.2013.08.294","volume":"172","author":"B Acharya","year":"2013","unstructured":"Acharya B, et al. In vivo imaging of myocardial cell death using a peptide probe and assessment of long-term heart function. J Control Release. 2013;172(1):367\u201373.","journal-title":"J Control Release"},{"issue":"5","key":"1968_CR53","doi-asserted-by":"publisher","first-page":"054010","DOI":"10.1117\/1.2114748","volume":"10","author":"JP Houston","year":"2005","unstructured":"Houston JP, et al. Quality analysis of in vivo near-infrared fluorescence and conventional gamma images acquired using a dual-labeled tumor-targeting probe. J Biomed Opt. 2005;10(5):054010.","journal-title":"J Biomed Opt"},{"issue":"2","key":"1968_CR54","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.ab.2008.09.050","volume":"384","author":"JL Kovar","year":"2009","unstructured":"Kovar JL, et al. Characterization and performance of a near-infrared 2-deoxyglucose optical imaging agent for mouse cancer models. Anal Biochem. 2009;384(2):254\u201362.","journal-title":"Anal Biochem"},{"key":"1968_CR55","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/978-1-4939-9199-0_16","volume":"1968","author":"A Sierakowiak","year":"2019","unstructured":"Sierakowiak A, Henriques-Normark B, Iovino F. IVIS spectrum CT to image the progression of Pneumococcal infections in vivo. Methods Mol Biol. 2019;1968:195\u2013202.","journal-title":"Methods Mol Biol"},{"issue":"11","key":"1968_CR56","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1002\/jcb.25545","volume":"117","author":"S Miwa","year":"2016","unstructured":"Miwa S, et al. Real-Time in vivo confocal fluorescence imaging of prostate cancer Bone-Marrow micrometastasis development at the cellular level in nude mice. J Cell Biochem. 2016;117(11):2533\u20137.","journal-title":"J Cell Biochem"},{"issue":"6","key":"1968_CR57","doi-asserted-by":"publisher","first-page":"e2302687","DOI":"10.1002\/adhm.202302687","volume":"13","author":"A Yang","year":"2024","unstructured":"Yang A, et al. Integrating fluorescence and magnetic resonance imaging in biocompatible scaffold for Real-Time bone repair monitoring and assessment. Adv Healthc Mater. 2024;13(6):e2302687.","journal-title":"Adv Healthc Mater"},{"issue":"8","key":"1968_CR58","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1021\/acs.langmuir.6b04038","volume":"33","author":"N Leo","year":"2017","unstructured":"Leo N, et al. Ionic strength, surface charge, and packing density effects on the properties of peptide Self-Assembled monolayers. Langmuir. 2017;33(8):2050\u20138.","journal-title":"Langmuir"},{"key":"1968_CR59","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.biomaterials.2015.11.013","volume":"77","author":"S Chen","year":"2016","unstructured":"Chen S, et al. A surface charge-switchable and folate modified system for co-delivery of proapoptosis peptide and p53 plasmid in cancer therapy. Biomaterials. 2016;77:149\u201363.","journal-title":"Biomaterials"},{"issue":"8","key":"1968_CR60","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1016\/j.biochi.2012.03.027","volume":"94","author":"R Sabate","year":"2012","unstructured":"Sabate R, et al. Effect of the surface charge of artificial model membranes on the aggregation of amyloid beta-peptide. Biochimie. 2012;94(8):1730\u20138.","journal-title":"Biochimie"},{"issue":"1","key":"1968_CR61","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40824-021-00212-y","volume":"25","author":"L Abarca-Cabrera","year":"2021","unstructured":"Abarca-Cabrera L, Fraga-Garcia P, Berensmeier S. Bio-nano interactions: binding proteins, polysaccharides, lipids and nucleic acids onto magnetic nanoparticles. Biomater Res. 2021;25(1):12.","journal-title":"Biomater Res"},{"issue":"1","key":"1968_CR62","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s11095-022-03430-8","volume":"40","author":"J Zhong","year":"2023","unstructured":"Zhong J, et al. Bone-Targeted dual functional Lipid-coated drug delivery system for osteosarcoma therapy. Pharm Res. 2023;40(1):231\u201343.","journal-title":"Pharm Res"},{"issue":"2","key":"1968_CR63","first-page":"189","volume":"3","author":"X Feng","year":"2009","unstructured":"Feng X. Chemical and biochemical basis of Cell-Bone matrix interaction in health and disease. Curr Chem Biol. 2009;3(2):189\u201396.","journal-title":"Curr Chem Biol"},{"issue":"1","key":"1968_CR64","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/jfb1010022","volume":"1","author":"SV Dorozhkin","year":"2010","unstructured":"Dorozhkin SV. Calcium orthophosphates as bioceramics: state of the Art. J Funct Biomater. 2010;1(1):22\u2013107.","journal-title":"J Funct Biomater"},{"issue":"7","key":"1968_CR65","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.biomaterials.2009.11.050","volume":"31","author":"SV Dorozhkin","year":"2010","unstructured":"Dorozhkin SV. Bioceramics of calcium orthophosphates. Biomaterials. 2010;31(7):1465\u201385.","journal-title":"Biomaterials"},{"key":"1968_CR66","doi-asserted-by":"publisher","first-page":"107603","DOI":"10.1016\/j.bioorg.2024.107603","volume":"150","author":"Z Chen","year":"2024","unstructured":"Chen Z, et al. Discovery of TCP-(MP)-caffeic acid analogs as a new class of agents for treatment of osteoclastic bone loss. Bioorg Chem. 2024;150:107603.","journal-title":"Bioorg Chem"},{"key":"1968_CR67","doi-asserted-by":"crossref","unstructured":"Goncalves Dos Santos G et al. Bone regeneration using Wollastonite\/beta-TCP scaffolds implants in critical bone defect in rat calvaria. Biomed Phys Eng Express, 2021. 7(5).","DOI":"10.1088\/2057-1976\/ac1878"},{"key":"1968_CR68","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.2147\/CIA.S157523","volume":"13","author":"K Li","year":"2018","unstructured":"Li K, et al. The good, the bad, and the ugly of calcium supplementation: a review of calcium intake on human health. Clin Interv Aging. 2018;13:2443\u201352.","journal-title":"Clin Interv Aging"},{"key":"1968_CR69","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jsbmb.2017.12.009","volume":"180","author":"SJ Wimalawansa","year":"2018","unstructured":"Wimalawansa SJ, Razzaque MS, Al-Daghri NM. Calcium and vitamin D in human health: hype or real? J Steroid Biochem Mol Biol. 2018;180:4\u201314.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2 Suppl","key":"1968_CR70","doi-asserted-by":"publisher","first-page":"S192","DOI":"10.1080\/07315724.2001.10719031","volume":"20","author":"RP Heaney","year":"2001","unstructured":"Heaney RP. Calcium needs of the elderly to reduce fracture risk. J Am Coll Nutr. 2001;20(2 Suppl):S192\u20137.","journal-title":"J Am Coll Nutr"},{"issue":"3","key":"1968_CR71","doi-asserted-by":"publisher","first-page":"L436","DOI":"10.1152\/ajplung.00066.2020","volume":"320","author":"J Jagtap","year":"2021","unstructured":"Jagtap J, et al. A rapid dynamic in vivo near-infrared fluorescence imaging assay to track lung vascular permeability after acute radiation injury. Am J Physiol Lung Cell Mol Physiol. 2021;320(3):L436\u201350.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1968_CR72","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/978-1-4939-3721-9_14","volume":"1444","author":"Q Lin","year":"2016","unstructured":"Lin Q, et al. Using fluorescence imaging to track drug delivery and guide treatment planning in vivo. Methods Mol Biol. 2016;1444:153\u201366.","journal-title":"Methods Mol Biol"},{"issue":"14","key":"1968_CR73","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1039\/D4BM00391H","volume":"12","author":"A Stellpflug","year":"2024","unstructured":"Stellpflug A, et al. From bone to nanoparticles: development of a novel generation of bone derived nanoparticles for image guided orthopedic regeneration. Biomater Sci. 2024;12(14):3633\u201348.","journal-title":"Biomater Sci"},{"key":"1968_CR74","doi-asserted-by":"crossref","unstructured":"Stellpflug A et al. Bone-derived nanoparticles (BNPs) enhance osteogenic differentiation via Notch signaling. Nanoscale Adv, 2024.","DOI":"10.1101\/2024.06.19.599760"},{"key":"1968_CR75","doi-asserted-by":"crossref","unstructured":"Stellpflug A, et al. Using digested and lyophilized bone matrices to enhance retention and sustained release of BMP-2 for bone regeneration. J Craniofac Surg; 2025.","DOI":"10.1097\/SCS.0000000000011595"},{"issue":"12","key":"1968_CR76","doi-asserted-by":"publisher","first-page":"e0225410","DOI":"10.1371\/journal.pone.0225410","volume":"14","author":"TD McRae","year":"2019","unstructured":"McRae TD, et al. Robust blind spectral unmixing for fluorescence microscopy using unsupervised learning. PLoS ONE. 2019;14(12):e0225410.","journal-title":"PLoS ONE"},{"issue":"1","key":"1968_CR77","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12868-022-00765-1","volume":"24","author":"V Sadashivaiah","year":"2023","unstructured":"Sadashivaiah V, et al. SUFI: an automated approach to spectral unmixing of fluorescent multiplex images captured in mouse and post-mortem human brain tissues. BMC Neurosci. 2023;24(1):6.","journal-title":"BMC Neurosci"},{"issue":"6","key":"1968_CR78","doi-asserted-by":"publisher","first-page":"064011","DOI":"10.1117\/1.3258838","volume":"14","author":"H Xu","year":"2009","unstructured":"Xu H, Rice BW. In-vivo fluorescence imaging with a multivariate curve resolution spectral unmixing technique. J Biomed Opt. 2009;14(6):064011.","journal-title":"J Biomed Opt"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01968-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-025-01968-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01968-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T13:02:39Z","timestamp":1774962159000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-025-01968-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":78,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1968"],"URL":"https:\/\/doi.org\/10.1007\/s13346-025-01968-9","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,15]]},"assertion":[{"value":"5 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were approved by the Institutional Animal Care and Use Committee (IACUC) of The Medical College of Wisconsin under protocol number AUA#00007936. All experiments were performed in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We as the authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}